Paprocka Renata, Kutkowska Jolanta, Paczkowska Ewelina, Mwaura Godwin Munroe, Eljaszewicz Andrzej, Helmin-Basa Anna
Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasza Str. 2, 85-089 Bydgoszcz, Poland.
Department of Genetics and Microbiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka Str. 19, 20-033 Lublin, Poland.
Molecules. 2025 Apr 21;30(8):1853. doi: 10.3390/molecules30081853.
In recent years, the incidence of acute and chronic inflammatory diseases has increased significantly worldwide, intensifying the search for new therapeutic agents, especially anti-inflammatory drugs. Therefore, the aim of this work was to synthesize, biologically assess, and explore the structure-activity relationships of new compounds containing the cyclohex-1-ene-1-carboxylic acid moiety. Six new derivatives, -, were synthesized through the reaction of amidrazones - with 3,4,5,6-tetrahydrophthalic anhydride. Their toxicity was evaluated in cultures of human peripheral blood mononuclear cells (PBMCs). Additionally, their antiproliferative properties and effects on the synthesis of TNF-α, IL-6, IL-10, and IL-1β were assessed in mitogen-stimulated PBMCs. The antimicrobial activity of derivatives - was determined by measuring the minimal inhibitory concentration (MIC) values against five bacterial strains-, , , , and -and the fungal strain All compounds demonstrated antiproliferative activity, with derivatives , , and at a concentration of 100 µg/mL being more effective than ibuprofen. Compound strongly inhibited the secretion of TNF-α by approximately 66-81% at all studied doses (10, 50, and 100 µg/mL). Derivative significantly reduced the release of cytokines, including TNF-α, IL-6, and IL-10, at a high dose (by approximately 92-99%). Compound exhibited bacteriostatic activity against and , while derivative selectively inhibited the growth of (MIC = 64 µg/mL). Some structure-activity relationships were established for the studied compounds.
近年来,急性和慢性炎症性疾病的发病率在全球范围内显著增加,这使得对新型治疗药物,尤其是抗炎药物的研发需求更为迫切。因此,本研究旨在合成、进行生物学评估并探索含有环己-1-烯-1-羧酸部分的新化合物的构效关系。通过脒腙类化合物与3,4,5,6-四氢邻苯二甲酸酐反应,合成了六种新衍生物。在人外周血单核细胞(PBMC)培养物中评估了它们的毒性。此外,还在丝裂原刺激的PBMC中评估了它们的抗增殖特性以及对TNF-α、IL-6、IL-10和IL-1β合成的影响。通过测量对五种细菌菌株(、、、和)和真菌菌株的最小抑菌浓度(MIC)值,确定了衍生物的抗菌活性。所有化合物均表现出抗增殖活性,浓度为100μg/mL时,衍生物、和比布洛芬更有效。在所有研究剂量(10、50和100μg/mL)下,化合物强烈抑制TNF-α的分泌,抑制率约为66-81%。高剂量时,衍生物显著降低了包括TNF-α、IL-6和IL-10在内的细胞因子的释放(降低约92-99%)。化合物对和具有抑菌活性,而衍生物选择性抑制的生长(MIC = 64μg/mL)。还为所研究的化合物建立了一些构效关系。